Problems › We Do Not Know Which Products Make Money › B2B SaaS
Every business has a line that everyone assumes is profitable, and it is usually the one being subsidised. B2B SaaS companies carry a specific bind here — growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics. Until that is priced, net revenue retention will keep moving for reasons nobody can attribute, and the debate about contribution by line will stay a matter of opinion.
Every business has a line that everyone assumes is profitable, and it is usually the one being subsidised. B2B SaaS companies carry a specific bind here — growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics. Until that is priced, net revenue retention will keep moving for reasons nobody can attribute, and the debate about contribution by line will stay a matter of opinion.
Product-level profit is genuinely hard because most costs are shared, and the usual allocation — by revenue — quietly guarantees the answer. Allocating overhead in proportion to revenue makes high-revenue lines look expensive and low-revenue lines look efficient, which is precisely backwards when the low-revenue line consumes disproportionate attention.
A workable approach allocates only what is genuinely traceable and leaves the rest unallocated. You end up with contribution by line and one honest pool of shared cost, which is far more useful than a fully-absorbed number that nobody trusts.
The result is usually uncomfortable. In most portfolios a minority of lines carries the whole thing, and at least one long-standing line has been losing money for years with everyone assuming otherwise.
These three together are the signature. One on its own usually points somewhere else.
✓ Product profitability is quoted as a company-wide gross margin
✓ Nobody has discontinued anything in years
✓ Two people give different answers about the same product line
The move that usually makes it worse. Fully absorbing overhead into product lines, which produces a precise number built on an arbitrary rule and gets defended because it looks rigorous.
It is for you if you run or finance a B2B SaaS company and product profitability is quoted as a company-wide gross margin. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a B2B SaaS company. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Cost Reduction & Efficiency · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Matrix Strategy, one of 29 engagements the platform runs. For B2B SaaS companies it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Almost never for the decision at hand. Traceable costs plus an unallocated pool gets you the ranking, and the ranking is what you act on. Full ABC is a project that frequently outlives the decision that prompted it.
Say so explicitly and price the support. A loss-making line that genuinely pulls profitable revenue is a marketing cost with a name, which is a fine thing to be — as long as somebody decided it.
Annually, and after any significant mix change. The ranking is more stable than the numbers, so the exercise gets cheaper each time.
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית